Hospitals and Ambulatory Settings Segment, by End User to Account Largest Share in ENT Devices Market during 2025-2031

According to our new research study on "ENT Devices Market Forecast to 2031 - Global Analysis - by Product Type, And End User," the market was valued at US$ 22.54 billion in 2024 to US$ 35.06 billion by 2031; the market is expected to register a CAGR of 6.6% during 2025-2031. The ENT devices market growth is attributed to the increasing prevalence of ENT disorders and the increasing adoption of minimally invasive ENT procedures.

Patients and healthcare providers opt for minimally invasive procedures as they reduce surgical trauma, shorten recovery times, lower complication risks, and minimize hospital stays. This demand has increased the use of advanced ENT devices such as rigid and flexible endoscopes, microdebriders, balloon dilation systems, and powered surgical instruments across hospitals, ambulatory surgical centers, and specialized ENT clinics. Balloon Sinuplasty is one of the notable innovations used in treating chronic rhinosinusitis. As per the Allergy and Asthma Network, chronic rhinosinusitis affects 5-10% of the adult population globally in 2024. This technique uses a small, flexible balloon catheter to open blocked sinus passageways, offering an alternative to traditional sinus surgery. Unlike conventional procedures, it can often be performed in outpatient settings under local anesthesia, with patients returning to normal activity within 24 to 48 hours. The increasing awareness has led to the incorporation of the balloon dilation systems by ENT specialists into routine practice. Similarly, endoscopic ear surgery (EES) has gained traction for procedures such as cholesteatoma removal and tympanoplasty. This approach, which avoids large incisions behind the ear, allows direct access to the middle ear through the ear canal using high-definition rigid endoscopes. It improves visualization while preserving normal anatomy, making it especially appealing in pediatric cases.

A rapidly advancing area is radiofrequency ablation (RFA) for obstructive sleep apnea (OSA) and nasal turbinate hypertrophy. RFA reduces soft tissue volume with minimal discomfort, offering an outpatient-based solution for patients unwilling or unable to undergo more invasive surgeries. As per CPAP.com, more than 1 billion people were estimated to be affected by OSA worldwide in 2024. Moreover, laser-assisted ENT surgeries, such as for vocal cord polyps or recurrent respiratory papillomatosis, are increasingly adopted in tertiary care centers. These procedures reduce bleeding, enhance precision, and allow faster healing. Therefore, growing patient and provider preference for minimally invasive ENT procedures is transforming ENT surgical care, which drives the growth of the ENT devices market

Based on Product type, the ENT devices market is segmented into diagnostic devices, surgical devices, hearing aids, hearing implants, and others. The surgical devices segment held a largest ENT devices market share in 2024, and hearing aids segment is expected to register a highest CAGR during 2025-2031. The surgical devices play a critical role in advancing the diagnosis, treatment, and management of various otolaryngological conditions. This segment encompasses a wide range of specialized instruments such as surgical drills, microdebriders, lasers, and powered instruments designed specifically for ENT surgeries. These devices facilitate minimally invasive procedures, reducing patient recovery times and postoperative pain, and improving surgical precision. For instance, the use of endoscopic sinus surgery devices allows surgeons to treat chronic sinusitis with enhanced visualization and accuracy, significantly improving patient outcomes compared to traditional open surgeries. Additionally, recent trends in surgical devices highlight the growing preference for technologies that integrate advanced imaging and navigation systems, which assist surgeons in complex procedures such as skull base surgery and cochlear implantation. The adoption of powered microdebriders has increased due to their efficiency in tissue removal and reduced surgical time. Laser devices are gaining traction due to their precision in soft tissue surgeries in nasal and throat cavities. Moreover, advancements in robotic-assisted ENT surgeries are also contributing to the expansion of this segment, allowing for greater dexterity and access in confined anatomical regions.

Based on end user, the market is segmented into ENT clinics, hospitals and ambulatory settings, others. The hospitals and ambulatory settings segment held the largest ENT devices market share in 2024, and the ENT clinics segment is estimated to register the higher CAGR during 2025-2031. Hospital and ambulatory settings reflect the increasing demand for advanced diagnostic and surgical solutions in both inpatient and outpatient care environments. Hospitals, with their comprehensive facilities and specialist teams, typically handle complex ENT cases requiring sophisticated equipment such as surgical microscopes, image-guided surgery systems, and advanced endoscopic tools. Meanwhile, ambulatory surgical centers (ASCs) and outpatient clinics offer cost-effective, convenient options for routine ENT procedures, including sinus surgeries, tonsillectomies, and hearing tests, fostering greater adoption of portable and minimally invasive devices. For instance, hospitals increasingly use 3D image-guided navigation systems during sinus and skull base surgeries to enhance precision and reduce complications. These technologies improve surgical outcomes and reduce hospital stay duration, aligning with the global shift toward value-based care. Simultaneously, ambulatory centers leverage compact endoscopes and digital otoscopes to perform quick diagnostics and minor procedures, promoting faster patient turnover and improved access to care. Additionally, hospitals and ambulatory centers are rapidly adopting telehealth-enabled devices to support remote consultations and follow-ups, further expanding the reach of ENT care.

Sonova Holding AG, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Olympus Corp, Stryker Corp, Karl Storz SE & Co KG, Smith & Nephew Plc, Demant AS, and Medtronic Plc are among the leading companies operating in the global ENT devices market.

Companies operating in the ENT devices market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the ENT devices market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall ENT devices market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as healthcare, media, and telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused on market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, type, end users, etc., which helps our clients to gain a deeper analytical understanding of various research topics.

Contact Us

If you have any queries about this report or would like further information, please contact us:

- North America: +1 646 491 9876

- Asia Pacific: +91 20 6727 8686

- Email: sales@theinsightpartners.com

Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the publisher,